These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 18756829
1. [Modern tendencies in treatment of endometrial cancer stage III C]. Ivanov SI. Akush Ginekol (Sofiia); 2008; 47(3):29-31. PubMed ID: 18756829 [Abstract] [Full Text] [Related]
2. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection]. Ivanov I. Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272 [Abstract] [Full Text] [Related]
3. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N. Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [Abstract] [Full Text] [Related]
4. Analysis of FIGO Stage IIIc endometrial cancer patients. McMeekin DS, Lashbrook D, Gold M, Johnson G, Walker JL, Mannel R. Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962 [Abstract] [Full Text] [Related]
5. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA. Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923 [Abstract] [Full Text] [Related]
6. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Nelson G, Randall M, Sutton G, Moore D, Hurteau J, Look K. Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373 [Abstract] [Full Text] [Related]
7. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Fujimoto T, Nanjyo H, Nakamura A, Yokoyama Y, Takano T, Shoji T, Nakahara K, Yamada H, Mizunuma H, Yaegashi N, Sugiyama T, Kurachi H, Sato A, Tanaka T. Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720 [Abstract] [Full Text] [Related]
8. Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer. Parthasarathy A, Kapp DS, Cheung MK, Shin JY, Osann K, Chan JK. Obstet Gynecol; 2007 Dec; 110(6):1237-43. PubMed ID: 18055715 [Abstract] [Full Text] [Related]
9. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer. Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA. Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193 [Abstract] [Full Text] [Related]
10. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C. J Natl Cancer Inst; 2008 Dec 03; 100(23):1707-16. PubMed ID: 19033573 [Abstract] [Full Text] [Related]
11. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Bristow RE, Zerbe MJ, Rosenshein NB, Grumbine FC, Montz FJ. Gynecol Oncol; 2000 Aug 03; 78(2):85-91. PubMed ID: 10926785 [Abstract] [Full Text] [Related]
12. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT. Gynecol Oncol; 2006 Jul 03; 102(1):92-7. PubMed ID: 16406063 [Abstract] [Full Text] [Related]
13. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Landrum LM, Moore KN, Myers TK, Lanneau GS, McMeekin DS, Walker JL, Gold MA. Gynecol Oncol; 2009 Feb 03; 112(2):337-41. PubMed ID: 19041126 [Abstract] [Full Text] [Related]
14. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes. Hoekstra AV, Kim RJ, Small W, Rademaker AW, Helenowski IB, Singh DK, Schink JC, Lurain JR. Gynecol Oncol; 2009 Aug 03; 114(2):273-8. PubMed ID: 19428094 [Abstract] [Full Text] [Related]
15. The benefit of adjuvant radiation therapy in single-node-positive squamous cell vulvar carcinoma. Parthasarathy A, Cheung MK, Osann K, Husain A, Teng NN, Berek JS, Kapp DS, Chan JK. Gynecol Oncol; 2006 Dec 03; 103(3):1095-9. PubMed ID: 16889821 [Abstract] [Full Text] [Related]
16. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS. Cancer; 2006 Oct 15; 107(8):1823-30. PubMed ID: 16977653 [Abstract] [Full Text] [Related]
17. [Modern tendencies in the surgical treatment of the early detected endometrial cancers--with or without lymph node dissection]. Akush Ginekol (Sofiia); 2008 Oct 15; 47(6):22-5. PubMed ID: 19230261 [Abstract] [Full Text] [Related]
18. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC. Gynecol Oncol; 2006 May 15; 101(2):200-8. PubMed ID: 16510174 [Abstract] [Full Text] [Related]
19. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery]. Ivanov S, Tomov S. Akush Ginekol (Sofiia); 2009 May 15; 48(3):14-9. PubMed ID: 20198758 [Abstract] [Full Text] [Related]